| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |